Guggenheim Doubts Salesforce's Agentic AI Agentforce as an Effective Growth Factor
Agentforce was launched in September and already signed up 200 companies to deploy Agentforce as their smarter chatbot. Marc ...
Guggenheim sees potential in Primoris, starts with a Buy
As previously reported, Guggenheim analyst Joseph Osha initiated coverage of Primoris (PRIM) with a Buy rating and $102 price target The firm ...
MongoDB Gains On Buy Call. Why Analyst Is Bullish Software Stock Can Shake Off Slump.
MongoDB stock was higher early Monday after analysts at Guggenheim upgraded their view on the company to a buy rating.
SpringWorks Therapeutics price target lowered to $78 from $80 at Guggenheim
Guggenheim analyst Michael Schmidt lowered the firm’s price target on SpringWorks Therapeutics (SWTX) to $78 from $80 and ...
Workday upgraded to Neutral at Guggenheim on reinvigorated growth
As previously reported, Guggenheim analyst John DiFucci upgraded Workday (WDAY) to Neutral from Sell with no price target While the firm still ...
Morningstar1d
Guggenheim Macro Opportunities A
Guggenheim has expanded its risk-management capabilities significantly in recent ‎‎years, though, and valuation-driven cutting of risk in 2018 and 2019—despite putting the strategy ...
Long Island Press1d
Guggenheim Elementary guest speaker shares experiences in Africa
Third-grade students at Guggenheim Elementary School were given a unique cultural experience on Jan. 3 when guest presenter ...
Salesforce Stock’s AI Rally Is Over, Analyst Says. Why Now Could Be the Time to Sell.
Salesforce ended 2024 on a high note but fell on Monday after a Guggenheim analyst downgraded shares of the software company.